Guardant Health, Inc.
GH · NASDAQ · USD
$167.42
+1.86 1.12%todayNot financial advice.
- Open
- 166.03
- Day range
- 166.03 - 170.81
- 52-week range
- 61.00 - 191.05
- Volume
- 1.23M
- Market cap
- 22.47B
- P/E ratio
- —
- EPS
- -3.5
- Dividend yield
- 0.00%
- Beta
- 0.92
Performance
W
−3.40%
1M
+3.82%
3M
+2.13%
6M
+92.19%
YTD
+63.66%
Y
+156.98%
5Y
+49.03%
All
+503.32%
In the news
Oct 8
Guardant Health Wins European Approval for Breast Cancer Diagnostic Test
Guardant Health has received European CE-marking for its Guardant360 CDx liquid biopsy to help identify breast cancer patients for an AstraZeneca treatment.
Company news
Oct 8
Guardant Health Earns European Approval for Breast Cancer Companion Diagnostic
Guardant Health (GH) secured European CE-marking for its Guardant360 CDx liquid biopsy to identify breast cancer patients for AstraZeneca's camizestrant.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-GH" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Guardant Health, Inc. (GH) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-GH">GH stock price</a> by FreeTheAI Stocks</p>